What We're Reading: Page 390
Industry reads hand-picked by our editors
Dec 09, 2014
-
CNBC
Merck to buy antibiotics powerhouse Cubist for $9.5 billion
-
Why CRO employee turnover is still so high
-
FDA: A defined biosimlar pathway is coming—soon
-
Merck, BMS PD-1 drugs continue to roll, show promise for Hodgkin's lymphoma
-
-
-
-
-
Some more firsts for Incyte: Jakafi approved for chronic bone marrow disease
-
Dec 08, 2014
-
-
Big pharma meets medical marijuana? Dutch firm to build cannabinoid gum factory
-
-
The FDA's new effort to make it easier to create generics of risky drugs
-
-
-
Google's secretive Calico looking to hire bioinformatics pro
-
-
-
GSK reverses course, retracts plan to sell older drugs
Dec 05, 2014
-
Whistleblower: Sanofi, ex-CEO Viehbacher paid out $34M in kickback scheme
-
-
FDA OKs Amgen's Blincyto to treat rare form of acute lymphoblastic leukemia
-
Confirmed: GSK to chop 900 jobs, mostly in North Carolina, in massive reorg
-
-
Mice infused with human brain cells shed light on cognitive function
-
-
Beyond ABC: FDA finalizes labeling rules for pregnant, lactating women
-
-
Actavis to lay off 200 workers in California
-
Dec 04, 2014
-
Security firm: Hackers trying to manipulate global markets by stealing pharma emails
-
-
A $945 million breakup: J&J, Astellas call off major rheumatoid arthritis deal
-
-
Promising Biogen Alzheimer's drug leapfrogs from phase I to phase III
-
-
-
Puma Biotech plummets in after hours trading after delaying breast cancer NDA
-
-
Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products
Dec 03, 2014
-
-
Mylan strikes deal to make Gilead's HIV drugs more accessible to poor nations
-
-
Done deal: Pfizer completes acquistion of Baxter's vaccines
-
Why BMS is getting ready to slash up to 1,000 jobs in China
-
-
Meet the healthcare and pharma industry vet who will be Teva's next chairman
-
-
-
Despite deaths, Italian regulators declare Novartis flu vaccine safe—for now
Dec 02, 2014
-
Job cuts ahead: GSK plans US workforce restructuring
-
-
-
EU green lights BI's Vargatef for advanced lung cancer
-
Report: China considering large-scale eradication of drug price caps
-
-
Glaxo/NIH Ebola vaccine elicits immune response in human trials
-
The key to successful clinical trial recruitment? Patient empowerment
-
-
Dec 01, 2014
-
Trouble for J&J? Amgen/AZ plaque psoriasis drug bests Stelara in phase III
-
-
Takeda US CEO leaving after 22 years
-
-
Lilly’s once-weekly diabetes drug approved in EU
-
-
-
FDA: No decision on Novartis' troubled panobinostat for 3 months
-
-
Generic drug price hikes move Congress to consider consumer relief measures
Previous
